APO Research
Talk to an analyst

APO RESEARCH · REPORT

Elisa Development and Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Elisa Development and Test Market Outlook and Growth Opportunities 2026

12 August 2026191 pages

Choose your research edition.

Industry ResearchElisa Development and Test Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Elisa Development and Test Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Elisa Development and Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Elisa Development and Test Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Elisa Development and Test Market Analysis and Forecast 2026-2032179 pages · $4,950 USD

Market perspective

The global Elisa Development and Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Elisa Development and Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Elisa Development and Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Elisa Development and Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Elisa Development and Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Elisa Development and Test market include Aviva Systems Biology, GTP Bioways, Thermo Fisher Scientific, Charles River, Bio-Techne, Biorbyt, STEFFENS BIOTEC, ARVYS Proteins and QED Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Elisa Development and Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Elisa Development and Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Elisa Development and Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Elisa Development and Test market.

Elisa Development and Test Segment by Company

Aviva Systems Biology

GTP Bioways

Thermo Fisher Scientific

Charles River

Bio-Techne

Biorbyt

STEFFENS BIOTEC

ARVYS Proteins

QED Bioscience

Capra Science Antibodies AB

Elisa Development and Test Segment by Type

Elisa Development

Elisa Test

Elisa Development and Test Segment by Application

Biotechnology

Laboratory

Others

Elisa Development and Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Elisa Development and Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Elisa Development and Test key companies, revenue, market share, and recent developments.

3. To split the Elisa Development and Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Elisa Development and Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Elisa Development and Test significant trends, drivers, influence factors in global and regions.

6. To analyze Elisa Development and Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Elisa Development and Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Elisa Development and Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Elisa Development and Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Elisa Development and Test industry.

Chapter 3: Detailed analysis of Elisa Development and Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Elisa Development and Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Elisa Development and Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Elisa Development and Test Industry Trends Table 2. Elisa Development and Test Industry Drivers Table 3. Elisa Development and Test Industry Opportunities and Challenges Table 4. Elisa Development and Test Industry Restraints Table 5. Global Elisa Development and Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Elisa Development and Test Revenue Share by Company (2021-2026) Table 7. Global Elisa Development and Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Elisa Development and Test Key Company Manufacturing Base & Headquarters Table 9. Global Elisa Development and Test Company, Product Type & Application Table 10. Global Elisa Development and Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Elisa Development and Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Elisa Development Table 15. Significant Companies of Elisa Test Table 16. Global Elisa Development and Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Elisa Development and Test Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Elisa Development and Test Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Elisa Development and Test Sales Value Share by Type (2021-2026) Table 20. Global Elisa Development and Test Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biotechnology Table 22. Significant Companies of Laboratory Table 23. Significant Companies of Others Table 24. Global Elisa Development and Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Elisa Development and Test Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Elisa Development and Test Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Elisa Development and Test Sales Value Share by Application (2021-2026) Table 28. Global Elisa Development and Test Sales Value Share by Application (2027-2032) Table 29. Global Elisa Development and Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Elisa Development and Test Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Elisa Development and Test Sales Value Share by Region (2021-2026) Table 32. Global Elisa Development and Test Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Elisa Development and Test Sales Value Share by Region (2027-2032) Table 34. Global Elisa Development and Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Elisa Development and Test Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Elisa Development and Test Sales Value Market Share by Country (2021-2026) Table 37. Global Elisa Development and Test Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Elisa Development and Test Sales Value Market Share by Country (2027-2032) Table 39. Aviva Systems Biology Company Information Table 40. Aviva Systems Biology Business Overview Table 41. Aviva Systems Biology Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Aviva Systems Biology Elisa Development and Test Product Portfolio Table 43. Aviva Systems Biology Recent Development Table 44. GTP Bioways Company Information Table 45. GTP Bioways Business Overview Table 46. GTP Bioways Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. GTP Bioways Elisa Development and Test Product Portfolio Table 48. GTP Bioways Recent Development Table 49. Thermo Fisher Scientific Company Information Table 50. Thermo Fisher Scientific Business Overview Table 51. Thermo Fisher Scientific Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Thermo Fisher Scientific Elisa Development and Test Product Portfolio Table 53. Thermo Fisher Scientific Recent Development Table 54. Charles River Company Information Table 55. Charles River Business Overview Table 56. Charles River Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Charles River Elisa Development and Test Product Portfolio Table 58. Charles River Recent Development Table 59. Bio-Techne Company Information Table 60. Bio-Techne Business Overview Table 61. Bio-Techne Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bio-Techne Elisa Development and Test Product Portfolio Table 63. Bio-Techne Recent Development Table 64. Biorbyt Company Information Table 65. Biorbyt Business Overview Table 66. Biorbyt Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Biorbyt Elisa Development and Test Product Portfolio Table 68. Biorbyt Recent Development Table 69. STEFFENS BIOTEC Company Information Table 70. STEFFENS BIOTEC Business Overview Table 71. STEFFENS BIOTEC Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. STEFFENS BIOTEC Elisa Development and Test Product Portfolio Table 73. STEFFENS BIOTEC Recent Development Table 74. ARVYS Proteins Company Information Table 75. ARVYS Proteins Business Overview Table 76. ARVYS Proteins Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ARVYS Proteins Elisa Development and Test Product Portfolio Table 78. ARVYS Proteins Recent Development Table 79. QED Bioscience Company Information Table 80. QED Bioscience Business Overview Table 81. QED Bioscience Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. QED Bioscience Elisa Development and Test Product Portfolio Table 83. QED Bioscience Recent Development Table 84. Capra Science Antibodies AB Company Information Table 85. Capra Science Antibodies AB Business Overview Table 86. Capra Science Antibodies AB Elisa Development and Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Capra Science Antibodies AB Elisa Development and Test Product Portfolio Table 88. Capra Science Antibodies AB Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Elisa Development and Test Product Image Figure 2. Global Elisa Development and Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Elisa Development and Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Elisa Development and Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Elisa Development Image Figure 8. Elisa Test Image Figure 9. Global Elisa Development and Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Elisa Development and Test Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Elisa Development and Test Sales Value Share by Type (2021-2032) Figure 12. Biotechnology Image Figure 13. Laboratory Image Figure 14. Others Image Figure 15. Global Elisa Development and Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Elisa Development and Test Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Elisa Development and Test Sales Value Share by Application (2021-2032) Figure 18. Global Elisa Development and Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Elisa Development and Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Elisa Development and Test Sales Value (2021-2032) & (US$ Million) Figure 21. North America Elisa Development and Test Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Elisa Development and Test Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Elisa Development and Test Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Elisa Development and Test Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Elisa Development and Test Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Elisa Development and Test Sales Value (2021-2032) & (US$ Million) Figure 27. South America Elisa Development and Test Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Elisa Development and Test Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Elisa Development and Test Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Elisa Development and Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Elisa Development and Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Elisa Development and Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Elisa Development
  • Elisa Test
Applications
  • Biotechnology
  • Laboratory
  • Others
Companies covered
  • Aviva Systems Biology
  • GTP Bioways
  • Thermo Fisher Scientific
  • Charles River
  • Bio-Techne
  • Biorbyt
  • STEFFENS BIOTEC
  • ARVYS Proteins
  • QED Bioscience
  • Capra Science Antibodies AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Elisa Development and Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Elisa Development and Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Elisa Development and Test Market Dynamics
  1. 2.1 Elisa Development and Test Industry Trends
  2. 2.2 Elisa Development and Test Industry Drivers
  3. 2.3 Elisa Development and Test Industry Opportunities and Challenges
  4. 2.4 Elisa Development and Test Industry Restraints
3 Elisa Development and Test Market by Company
  1. 3.1 Global Elisa Development and Test Company Revenue Ranking in 2025
  2. 3.2 Global Elisa Development and Test Revenue by Company (2021-2026)
  3. 3.3 Global Elisa Development and Test Company Ranking (2024-2026)
  4. 3.4 Global Elisa Development and Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Elisa Development and Test Company Product Type and Application
  6. 3.6 Global Elisa Development and Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Elisa Development and Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Elisa Development and Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Elisa Development and Test Market by Type
  1. 4.1 Elisa Development and Test Type Introduction
  2. 4.1.1 Elisa Development
  3. 4.1.2 Elisa Test
  4. 4.2 Global Elisa Development and Test Sales Value by Type
  5. 4.2.1 Global Elisa Development and Test Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Elisa Development and Test Sales Value by Type (2021-2032)
  7. 4.2.3 Global Elisa Development and Test Sales Value Share by Type (2021-2032)
5 Elisa Development and Test Market by Application
  1. 5.1 Elisa Development and Test Application Introduction
  2. 5.1.1 Biotechnology
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Elisa Development and Test Sales Value by Application
  6. 5.2.1 Global Elisa Development and Test Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Elisa Development and Test Sales Value by Application (2021-2032)
  8. 5.2.3 Global Elisa Development and Test Sales Value Share by Application (2021-2032)
6 Elisa Development and Test Regional Value Analysis
  1. 6.1 Global Elisa Development and Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Elisa Development and Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Elisa Development and Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Elisa Development and Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Elisa Development and Test Sales Value (2021-2032)
  7. 6.3.2 North America Elisa Development and Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Elisa Development and Test Sales Value (2021-2032)
  10. 6.4.2 Europe Elisa Development and Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Elisa Development and Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Elisa Development and Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Elisa Development and Test Sales Value (2021-2032)
  16. 6.6.2 South America Elisa Development and Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Elisa Development and Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Elisa Development and Test Sales Value Share by Country, 2025 VS 2032
7 Elisa Development and Test Country-level Value Analysis
  1. 7.1 Global Elisa Development and Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Elisa Development and Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Elisa Development and Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Elisa Development and Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Elisa Development and Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Elisa Development and Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Elisa Development and Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Elisa Development and Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Elisa Development and Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Elisa Development and Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Elisa Development and Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Elisa Development and Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Elisa Development and Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Elisa Development and Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Elisa Development and Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Elisa Development and Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Elisa Development and Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Elisa Development and Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Elisa Development and Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Elisa Development and Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Elisa Development and Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Elisa Development and Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Elisa Development and Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Elisa Development and Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Elisa Development and Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Elisa Development and Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Elisa Development and Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Elisa Development and Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Elisa Development and Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Elisa Development and Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Elisa Development and Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Elisa Development and Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Elisa Development and Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Elisa Development and Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aviva Systems Biology
  2. 8.1.1 Aviva Systems Biology Company Information
  3. 8.1.2 Aviva Systems Biology Business Overview
  4. 8.1.3 Aviva Systems Biology Elisa Development and Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aviva Systems Biology Elisa Development and Test Product Portfolio
  6. 8.1.5 Aviva Systems Biology Recent Developments
  7. 8.2 GTP Bioways
  8. 8.2.1 GTP Bioways Company Information
  9. 8.2.2 GTP Bioways Business Overview
  10. 8.2.3 GTP Bioways Elisa Development and Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GTP Bioways Elisa Development and Test Product Portfolio
  12. 8.2.5 GTP Bioways Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Elisa Development and Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Elisa Development and Test Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 Charles River
  20. 8.4.1 Charles River Company Information
  21. 8.4.2 Charles River Business Overview
  22. 8.4.3 Charles River Elisa Development and Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Elisa Development and Test Product Portfolio
  24. 8.4.5 Charles River Recent Developments
  25. 8.5 Bio-Techne
  26. 8.5.1 Bio-Techne Company Information
  27. 8.5.2 Bio-Techne Business Overview
  28. 8.5.3 Bio-Techne Elisa Development and Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Techne Elisa Development and Test Product Portfolio
  30. 8.5.5 Bio-Techne Recent Developments
  31. 8.6 Biorbyt
  32. 8.6.1 Biorbyt Company Information
  33. 8.6.2 Biorbyt Business Overview
  34. 8.6.3 Biorbyt Elisa Development and Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biorbyt Elisa Development and Test Product Portfolio
  36. 8.6.5 Biorbyt Recent Developments
  37. 8.7 STEFFENS BIOTEC
  38. 8.7.1 STEFFENS BIOTEC Company Information
  39. 8.7.2 STEFFENS BIOTEC Business Overview
  40. 8.7.3 STEFFENS BIOTEC Elisa Development and Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 STEFFENS BIOTEC Elisa Development and Test Product Portfolio
  42. 8.7.5 STEFFENS BIOTEC Recent Developments
  43. 8.8 ARVYS Proteins
  44. 8.8.1 ARVYS Proteins Company Information
  45. 8.8.2 ARVYS Proteins Business Overview
  46. 8.8.3 ARVYS Proteins Elisa Development and Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ARVYS Proteins Elisa Development and Test Product Portfolio
  48. 8.8.5 ARVYS Proteins Recent Developments
  49. 8.9 QED Bioscience
  50. 8.9.1 QED Bioscience Company Information
  51. 8.9.2 QED Bioscience Business Overview
  52. 8.9.3 QED Bioscience Elisa Development and Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 QED Bioscience Elisa Development and Test Product Portfolio
  54. 8.9.5 QED Bioscience Recent Developments
  55. 8.10 Capra Science Antibodies AB
  56. 8.10.1 Capra Science Antibodies AB Company Information
  57. 8.10.2 Capra Science Antibodies AB Business Overview
  58. 8.10.3 Capra Science Antibodies AB Elisa Development and Test Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Capra Science Antibodies AB Elisa Development and Test Product Portfolio
  60. 8.10.5 Capra Science Antibodies AB Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst